Trials / Withdrawn
WithdrawnNCT06488066
Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Vance Thompson Vision · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this investigator initiated study (IIT-002) is to collect data on commercial patients implanted with the RxSight Light Adjustable Lens (LAL).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collection | Collection of clinical data from groups of patients already implanted with the light adjustable lens (LAL) and have completed light treatments. |
Timeline
- Start date
- 2021-08-13
- Primary completion
- 2022-01-01
- Completion
- 2022-01-01
- First posted
- 2024-07-05
- Last updated
- 2024-07-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06488066. Inclusion in this directory is not an endorsement.